Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122445077 | 12244507 | 7 | F | 201209 | 20160923 | 20160407 | 20160926 | EXP | CA-ROCHE-1132730 | ROCHE | 65.96 | YR | F | Y | 61.50000 | KG | 20160926 | CN | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122445077 | 12244507 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | SOLUTION FOR INFUSION | |||||||
| 122445077 | 12244507 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 516 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 285 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 4 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 258 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 5 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 512 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 6 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 258 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 7 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 246 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 8 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 248 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 9 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 252 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 10 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | N | B20051,B20071,B2005B261,B2006B281,B | 125276 | 250 | MG | SOLUTION FOR INFUSION | |||||
| 122445077 | 12244507 | 11 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 122445077 | 12244507 | 12 | C | CELEBREX | CELECOXIB | 1 | 0 | ||||||||||||
| 122445077 | 12244507 | 13 | C | ASA | ASPIRIN | 1 | Unknown | 0 | 81 | MG | |||||||||
| 122445077 | 12244507 | 14 | C | TYLENOL | ACETAMINOPHEN | 1 | 0 | ||||||||||||
| 122445077 | 12244507 | 15 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 122445077 | 12244507 | 16 | C | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | 1 | 0 | ||||||||||||
| 122445077 | 12244507 | 17 | C | METOPROLOL. | METOPROLOL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122445077 | 12244507 | 1 | Rheumatoid arthritis |
| 122445077 | 12244507 | 17 | Blood pressure measurement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122445077 | 12244507 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122445077 | 12244507 | Bite | |
| 122445077 | 12244507 | Blood pressure increased | |
| 122445077 | 12244507 | Blood pressure systolic increased | |
| 122445077 | 12244507 | Cough | |
| 122445077 | 12244507 | Fatigue | |
| 122445077 | 12244507 | Gingival erythema | |
| 122445077 | 12244507 | Gingival swelling | |
| 122445077 | 12244507 | Gingivitis | |
| 122445077 | 12244507 | Heart rate decreased | |
| 122445077 | 12244507 | Influenza | |
| 122445077 | 12244507 | Infusion related reaction | |
| 122445077 | 12244507 | Musculoskeletal stiffness | |
| 122445077 | 12244507 | Nasopharyngitis | |
| 122445077 | 12244507 | Nodule | |
| 122445077 | 12244507 | Oral infection | |
| 122445077 | 12244507 | Oxygen saturation decreased | |
| 122445077 | 12244507 | Pain | |
| 122445077 | 12244507 | Peripheral swelling | |
| 122445077 | 12244507 | Pyrexia | |
| 122445077 | 12244507 | Quality of life decreased | |
| 122445077 | 12244507 | Sinusitis | |
| 122445077 | 12244507 | Swelling | |
| 122445077 | 12244507 | Thyroid mass | |
| 122445077 | 12244507 | Tooth abscess | |
| 122445077 | 12244507 | Toothache | |
| 122445077 | 12244507 | Weight decreased | |
| 122445077 | 12244507 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122445077 | 12244507 | 1 | 20101026 | 0 | ||
| 122445077 | 12244507 | 2 | 20101221 | 0 | ||
| 122445077 | 12244507 | 3 | 20110405 | 0 | ||
| 122445077 | 12244507 | 4 | 20110503 | 0 | ||
| 122445077 | 12244507 | 5 | 20101123 | 0 | ||
| 122445077 | 12244507 | 6 | 20121002 | 0 | ||
| 122445077 | 12244507 | 7 | 20131119 | 0 | ||
| 122445077 | 12244507 | 8 | 20140703 | 0 | ||
| 122445077 | 12244507 | 9 | 20150708 | 0 | ||
| 122445077 | 12244507 | 10 | 20160707 | 0 |